|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu
L and He J: Report of incidence and mortality in China cancer
registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
|
|
3
|
Parkin DM, Pisani P, Lopez AD and Masuyer
E: At least one in seven cases of cancer is caused by smoking.
Global estimates for 1985. Int J Cancer. 59:494–504. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Guen L, Karpanen T, Schulte D, Harris
NC, Koltowska K, Roukens G, Bower NI, van Impel A, Stacker SA,
Achen MG, et al: Ccbe1 regulates Vegfc-mediated induction of Vegfr3
signaling during embryonic lymphangiogenesis. Development.
141:1239–1249. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stacker SA, Williams SP, Karnezis T,
Shayan R, Fox SB and Achen MG: Lymphangiogenesis and lymphatic
vessel remodelling in cancer. Nat Rev Cancer. 14:159–172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bos FL, Caunt M, Peterson-Maduro J,
Planas-Paz L, Kowalski J, Karpanen T, van Impel A, Tong R, Ernst
JA, Korving J, et al: CCBE1 is essential for mammalian lymphatic
vascular development and enhances the lymphangiogenic effect of
vascular endothelial growth factor-C in vivo. Circ Res.
109:486–491. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hogan BM, Bos FL, Bussmann J, Witte M, Chi
NC, Duckers HJ and Schulte-Merker S: Ccbe1 is required for
embryonic lymphangiogenesis and venous sprouting. Nat Genet.
41:396–398. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alders M, Hogan BM, Gjini E, Salehi F,
Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF,
Offerhaus GJ, et al: Mutations in CCBE1 cause generalized lymph
vessel dysplasia in humans. Nat Genet. 41:1272–1274. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gordon K, Schulte D, Brice G, Simpson MA,
Roukens MG, van Impel A, Connell F, Kalidas K, Jeffery S, Mortimer
PS, et al: Mutation in vascular endothelial growth factor-C, a
ligand for vascular endothelial growth factor receptor-3, is
associated with autosomal dominant milroy-like primary lymphedema.
Circ Res. 112:956–960. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Li W, Zhang D, Kang S, Ding L and
Zhao S: The expression and clinical significance of CCBE1 in throat
cancer. J Shanxi Med Uni. 43:58–61. 2012.
|
|
11
|
Li W, Wang Y, Liu Y, Yin G and Feng K:
Prognosis of CCBE1 expression in colorectal cancer. Chin J
Gerontol. 7:3849–3850. 2014.
|
|
12
|
Jeltsch M, Jha SK, Tvorogov D, Anisimov A,
Leppänen VM, Holopainen T, Kivelä R, Ortega S, Kärpanen T and
Alitalo K: CCBE1 enhances lymphangiogenesis via A disintegrin and
metalloprotease with thrombospondin motifs-3-mediated vascular
endothelial growth factor-C activation. Circulation. 129:1962–1971.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu G, Li J, He L, Wang X and Hong X:
MPTP-induced changes in hippocampal synaptic plasticity and memory
are prevented by memantine through the BDNF-TrkB pathway. Br J
Pharmacol. 172:2354–2368. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu S, Cao J, Zhang T, Zhou Y, Wang K, Zhu
G and Zhou M: Electroacupuncture ameliorates the coronary occlusion
related tachycardia and hypotension in acute rat myocardial
ischemia model: Potential role of hippocampus. Evid Based
Complement Alternat Med. 2015:9259872015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barton CA, Gloss BS, Qu W, Statham AL,
Hacker NF, Sutherland RL, Clark SJ and O'Brien PM: Collagen and
calcium-binding EGF domains 1 is frequently inactivated in ovarian
cancer by aberrant promoter hypermethylation and modulates cell
migration and survival. Br J Cancer. 102:87–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Connell FC, Kalidas K, Ostergaard P, Brice
G, Murday V, Mortimer PS, Jeffrey I, Jeffery S and Mansour S: CCBE1
mutations can cause a mild, atypical form of generalized lymphatic
dysplasia but are not a common cause of non-immune hydrops fetalis.
Clin Genet. 81:191–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shah S, Conlin LK, Gomez L, Aagenaes Ø,
Eiklid K, Knisely AS, Mennuti MT, Matthews RP, Spinner NB and Bull
LN: CCBE1 mutation in two siblings, one manifesting
lymphedema-cholestasis syndrome, and the other, fetal hydrops. PLoS
One. 8:e757702013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roukens MG, Peterson-Maduro J, Padberg Y,
Jeltsch M, Leppänen VM, Bos FL, Alitalo K, Schulte-Merker S and
Schulte D: Functional dissection of the CCBE1 protein: A crucial
requirement for the collagen repeat domain. Circ Res.
116:1660–1669. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu HT, Xing AY, Chen X, Ma RR, Wang YW,
Shi DB, Zhang H, Li P, Chen HF, Li YH and Gao P: MicroRNA-27b,
microRNA-101 and microRNA-128 inhibit angiogenesis by
down-regulating vascular endothelial growth factor C expression in
gastric cancers. Oncotarget. 6:37458–37470. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jackson DG: The lymphatics revisited: New
perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc
Med. 13:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramani P, Dungwa JV and May MT: LYVE-1
upregulation and lymphatic invasion correlate with adverse
prognostic factors and lymph node metastasis in neuroblastoma.
Virchows Arch. 460:183–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tomita T: Lymphatic vessel endothelial
hyaluronan receptor 1 immunocytochemical staining for pancreatic
islets and pancreatic endocrine tumors. Pancreas. 35:e18–e22. 2007.
View Article : Google Scholar : PubMed/NCBI
|
